Reality Check on Heriditary Angioedema
Market access for HAE treatments reveals differences in payer coverage across each major channel, as well as specific trends in the drug landscape.
To help make sense of this new research, MMIT's team of experts has analyzed the data for you and summarized the key findings:
- Payer Insights: What increasing payer restrictions mean for HAE treatments
- Class Trends: How actions to block charitable premiums and co-pay assistance programs could affect the market
- Key Findings: Expect an increasingly competitive landscape once more prophylactics hit the market
What can pharma do to curb this trend and overcome these challenges?
Get the data behind this change and how it could impact your market access plans from MMIT's team. Their clinical and policy backgrounds provide a unique and expert perspective to help expand your knowledge in the class and guide your decision-making process.
Download the full Reality Check now.